RXR agonist

1 marketed 1 in Phase 3

This page covers all RXR agonist drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting RXR (Retinoid X Receptor), Retinoid X receptor (RXR).

Targets

RXR (Retinoid X Receptor) · Retinoid X receptor (RXR)

Marketed (1)

ROP · GlaxoSmithKline · Metabolic/Oncology
ROP is a retinoid X receptor (RXR) agonist that modulates nuclear receptor signaling to regulate gene expression involved in metabolic and inflammatory pathways.

Phase 3 pipeline (1)

Vehicle to AGN-229666 · Allergan · Dermatology or Ophthalmology
AGN-229666 is a selective retinoid X receptor (RXR) agonist that modulates nuclear receptor signaling to reduce inflammation and promote tissue repair.